• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[시사저널e] [바이오 줌人] 김건수 큐로셀 대표 “내년 국산 CAR-T 치료제 상용화”

2024/02/14

[바이오 줌人] 김건수 큐로셀 대표 “내년 국산 CAR-T 치료제 상용화” < 제약/바이오 < 기사본문 – 시사저널e (sisajournal-e.com)

Prev큐로셀 ‘안발셀’, 2차 중추신경계 림프종 환자 대상 연구자 임상 승인
Next[이투데이] 김건수 큐로셀 대표 “국산 CAR-T 상업화·흑자전환 임박” [상장 새내기 바이오①]
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.